Quantcast

Voices Against Brain Cancer Discusses a New Device That Helps Treat Brain Cancer

January 17, 2014

In response to an article published by CBS Philly, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, elaborates on a new, cap-like device that helps treat brain cancer.

New York, NY (PRWEB) January 17, 2014

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by CBS Philly on January 14, 2014 which reports on a new device worn by a brain cancer patient that can help treat the terrible disease.

According to the CBS Philly article titled “Health: Cap Tested Locally for Deadly Brain Cancer”, the cap-like contraption sends electric signals to the cancerous area of the brain, stopping the cells from dividing.

For cancer to spread throughout the body, cells have to divide in order to grow. Since the electric signals from the cap stop the cancerous cells from dividing, the cap can delay the process. The device, officially known as the Novo-Cure Cap, does not cure the patient of brain cancer, but it can help extend the patient’s life for a few months when used in conjunction with chemotherapy and radiation.

Currently the FDA has only approved the use of this cap for those diagnosed with recurring gliobastoma, the deadliest form of brain cancer.

Michael Klipper, Chairman of Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, believes this is a comforting option for those with brain cancer. “Brain cancer is one of the deadliest forms of cancer because of how quickly it spreads and due to its almost inevitable reoccurrence,” he says. “This device helps extend the patient’s life, and that’s a blessing for some families and friends to have a few more months with their loved ones. Hopefully this is something doctors can build on to find a cure.”

VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, Johns Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.

For the original version on PRWeb visit: http://www.prweb.com/releases/braincancer/VABC/prweb11499700.htm


Source: prweb



comments powered by Disqus